Ryan Bushey
Digital Editor

Ryan Bushey is a digital editor for Advantage Business Media’s Science Group.  He covers scientific discoveries, emerging technologies and the business of the life sciences sector for R&D Magazine and Drug Discovery & Development along with managing social media for both publications. He’s an experienced journalist whose work has appeared in Business Insider, Slate, and Indiewire.

MDX has traversed a difficult path during the research and development process.
Digital Editor
|
1.18.2017
7:42am
President-elect Donald Trump went after the pharmaceutical industry in the opening remarks of his first press conference since the election.
Digital Editor
|
1.12.2017
8:32am
The Cambridge, Massachusetts-based biotech company has kept its pipeline a secret until now.
Digital Editor
|
1.11.2017
9:52am
Japanese drugmaker Takeda acquired Boston-based Ariad Pharmaceuticals, a biotech company specializing in cancer drugs.
Digital Editor
|
1.10.2017
8:34am
The biotech startup wants to use this new funding to advance development of its specialized early detection cancer test.
Digital Editor
|
1.9.2017
8:29am
Advertisement
The Foster City, California-based biotech added a top cancer specialist to its executive ranks.
Digital Editor
|
1.5.2017
8:35am
An analysis published by Deloitte’s Centre for Health Solutions indicated the pharmaceutical industry experienced a continued decline in R&D returns for...
Digital Editor
|
1.3.2017
8:37am
Other researchers have used similar methods to sift through large amounts of data in order to pinpoint promising compounds to treat diseases.
Digital Editor
|
12.30.2016
11:08am
These articles provide a snapshot of the change the pharmaceutical industry experienced throughout the year.
Digital Editor
|
12.21.2016
8:30am
A new report explains how hospitals are implementing aggressive new measures to cut pharmaceutical spending in the face of rapidly rising prices for certain...
Digital Editor
|
12.20.2016
8:29am
Novartis is bolstering its dermatology portfolio with a new acquisition.
Digital Editor
|
12.19.2016
8:18am
Voyager Therapeutics is testing an experimental gene therapy that could boost Parkinson’s patients’ responses to levodopa.
Digital Editor
|
12.15.2016
9:00am
Eli Lilly will launch a new program in conjunction with Express Scripts to offer diabetes patients lower prices for its insulin products.
Digital Editor
|
12.13.2016
2:16pm
Advertisement
Bayer in conjunction with Versant Ventures are investing up to $225 million in a startup called Bluerock Therapeutics in one of the largest Series A funding...
Digital Editor
|
12.13.2016
8:16am
Biogen reported more encouraging data for its experimental Alzheimer’s treatment aducanumab on Thursday.
Digital Editor
|
12.12.2016
8:14am
The transition team for President-elect Donald Trump is reportedly exploring an unusual pick to run the Food and Drug Administration.
Digital Editor
|
12.9.2016
10:46am
Part of this restructuring process will include cutting less than 10 percent of its global workforce.
Digital Editor
|
12.8.2016
8:24am
Heather Bresch came to the fifth annual Forbes Healthcare conference to talk about the fallout from the EpiPen pricing controversy.
Digital Editor
|
12.5.2016
8:29am
This condition produces mutations that lead to a serious shortage of white blood cells.
Digital Editor
|
11.30.2016
8:32am
Approximately 400,000 people all over the world are living with either hemophilia A or hemophilia B.
Digital Editor
|
11.29.2016
9:58am
An experimental Alzheimer’s drug being developed by Eli Lilly failed to slow cognitive decline in patients with even a mild form of the condition.
Digital Editor
|
11.28.2016
8:50am
Advertisement
Novartis is boosting its hematology pipeline with a new acquisition.
Digital Editor
|
11.22.2016
9:51am
Amgen and Novartis are one step closer to having a contender in the migraine treatment space.
Digital Editor
|
11.17.2016
10:01am
Amgen announced good news for its cholesterol drug Repatha at the annual American Heart Association meeting taking place in New Orleans.
Digital Editor
|
11.16.2016
8:35am
Drug makers are working with companies like Propeller Health on these devices because they could provide improved adherence and better health outcomes.
Digital Editor
|
11.14.2016
8:29am
The biotech company will pay $100 million upfront to Japan’s Nitto Denko who developed this drug.
Digital Editor
|
11.10.2016
9:54am
Roche’s cancer drug business could soon face some competition.
Digital Editor
|
11.9.2016
8:00am
Currently, there are no approved drugs for spinal muscular atrophy.
Digital Editor
|
11.8.2016
9:53am
Nestle’s health science unit is expanding its presence in the biotech space with a new investment.
Digital Editor
|
11.7.2016
8:28am
One of the world’s largest food and beverage companies is launching a new initiative to help children all over the world.
Digital Editor
|
11.4.2016
8:34am
This endeavor could solve a difficult problem associated with drug development.
Digital Editor
|
11.2.2016
3:12pm
The new financing will be used to advance the firm’s cellular senescence research programs and commence clinical research.
Digital Editor
|
11.2.2016
8:36am
The Auvi-Q injector is making a comeback.
Digital Editor
|
10.27.2016
11:54am
A new study exonerates Gaetan Dugas, a French-Canadian flight attendant long considered to be “Patient Zero” in the 1980’s AIDS epidemic in the U.S.
Digital Editor
|
10.27.2016
8:20am
GlaxoSmithKline is preparing to challenge Merck for control over the shingles vaccine market.
Digital Editor
|
10.25.2016
9:33am
Alkermes saw its shares surge on Thursday after releasing new trial data related to its experimental drug to treat major depressive disorder, ALKS 5461.
Digital Editor
|
10.24.2016
9:20am
The biotech company announced new study results on Thursday for two experimental therapies.
Digital Editor
|
10.21.2016
1:44pm
The funding will be allocated to a mix of academic institutions and private companies.
Digital Editor
|
10.19.2016
8:17am
The drug maker initiated a series of wholesale price increases for therapies in three portfolios.
Digital Editor
|
10.18.2016
8:23am